Intas Pharmaceuticals Limited

Indian pharmaceutical company with diverse therapeutic areas, international exports, and multiple approved manufacturing facilities.

1985 | Ahmedabad, Gujarat (India) | Active
Last Updated:

Intas Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 175.47 Cr
  • Paid Up Capital ₹ 114.77 Cr
  • Company Age 39 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 4.50 Cr
  • Satisfied Charges ₹ 7,924.94 Cr
  • Revenue Growth -3.44%
  • Profit Growth -17.74%
  • Ebitda -18.86%
  • Net Worth 13.06%
  • Total Assets 8.17%

About Intas Pharmaceuticals

Intas Pharmaceuticals Limited (IPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 31 May 1985 and has a history of 39 years and nine months. Its registered office is in Ahmedabad, Gujarat, India.

The Corporate was formerly known as Intas Laboratories Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 175.47 Cr and a paid-up capital of Rs 114.77 Cr.

The company currently has active open charges totaling ₹4.50 Cr. The company has closed loans amounting to ₹7,924.94 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Intas Pharmaceuticals Limited India are Rakesh Bamzai as Ceo, Abhimanyu Ojha as Cfo, and Manoj Nair as Company Secretary. Urmish Chudgar, Binish Chudgar, Hasmukh Chudgar, and Six other members serve as directors at the Company.

Company Details

  • Location

    Ahmedabad, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    intaspharma.com

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24231GJ1985PLC007866

  • Company No.

    007866

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    31 May 1985

  • Date of AGM

    31 Jul 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Pharma

What products or services does Intas Pharmaceuticals Limited offer?

Intas Pharmaceuticals Limited offers a wide range of products and services, including Hair Care, Hair Growth for Men, Specialty Supplements, Probiotics, Skin Care, Facewash, Vitamins & Supplements, Vitamins A-Z, Health Conditions, Kidney Care.

Who are the key members and board of directors at Intas Pharmaceuticals?

Executive Team (6)

NameDesignationAppointment DateStatus
Urmish Chudgar Country flag representing In Managing Director30-Sep-1996Current
Binish Chudgar Country flag representing In Managing Director31-May-1985Current
Nimish Chudgar Country flag representing In Managing Director31-May-1985Current
Rakesh Bamzai Country flag representing In CEO11-Oct-2024Current
Abhimanyu Ojha CFO11-Oct-2024Current
Manoj Nair Country flag representing In Company Secretary08-Jun-2007Current

Board Members (6)

NameDesignationAppointment DateStatus
Hasmukh Chudgar Country flag representing In Director 31-May-1985Current
Sanjay Kukreja Country flag representing In Director 21-May-2020Current
Jayesh Shah Country flag representing In Whole-Time Director 21-Mar-2018Current
Venkatesh Ratnasami Country flag representing In Nominee Director 13-Nov-2014Current
Archana Dholakia Country flag representing In Director 14-Jun-2023Current
Jitesh Gadhia Additional Director 19-Sep-2024Current

Financial Performance of Intas Pharmaceuticals.

Intas Pharmaceuticals Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.44% decrease. The company also saw a substantial fall in profitability, with a 17.74% decrease in profit. The company's net worth Soared by an impressive increase of 13.06%.

Intas Pharmaceuticals revenue growth over time
Intas Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-3.44%
Revenue from Operations
-4.33%
Total Assets
8.17%
Profit or Loss
-17.74%
Net Worth
13.06%
EBITDA
-18.86%

What is the Ownership and Shareholding Structure of Intas Pharmaceuticals?

In 2024, Intas Pharmaceuticals had a promoter holding of 83.84% and a public holding of 16.16%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹4.50 Cr

Satisfied Charges

₹7,924.94 Cr

Charges Breakdown by Lending Institutions

  • Dena Bank : 4.50 Cr

Latest Charge Details

DateLenderAmountStatus
01 May 1998Dena Bank₹4.50 CrOpen
04 Sep 2017Standard Chartered Bank₹184.62 CrSatisfied
28 Dec 2016Others₹3,218.29 CrSatisfied
28 Dec 2016Others₹1,845.87 CrSatisfied
21 Mar 2016Citi Bank N.A.₹115.00 CrSatisfied

How Many Employees Work at Intas Pharmaceuticals?

Intas Pharmaceuticals has a workforce of 19974 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Intas Pharmaceuticals Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Intas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intas Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Intas Pharmaceuticals

Recent activity within the organization

  • Director Appointment

    Rakesh Bamzai was appointed as a Ceo was appointed as a Ceo on 11 Oct 2024 & has been associated with this company since 4 months 24 days .

  • Director Appointment

    Abhimanyu Ojha was appointed as a Cfo was appointed as a Cfo on 11 Oct 2024 & has been associated with this company since 4 months 24 days .

  • Charges

    A charge registered on 25 Jun 1999 via Charge ID 90103163 with Others was fully satisfied on 01 Oct 2024.

  • Director Appointment

    Jitesh Kishorekumar Gadhia was appointed as a Additional Director was appointed as a Additional Director on 19 Sep 2024 & has been associated with this company since 5 months 15 days .

  • Annual General Meeting

    Intas Pharmaceuticals Limited last Annual general meeting of members was held on 31 Jul 2024 as per latest MCA records.

  • Balance Sheet

    Intas Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.

Recent News, Updates & Announcement

Frequently asked questions

  • What is the Incorporation or founding date of Intas Pharmaceuticals Limited?

    Intas Pharmaceuticals Limited was incorporated on 31 May 1985.

  • What is authorized share capital and paid-up capital of Intas Pharmaceuticals Limited?

    The authorized share capital of Intas Pharmaceuticals Limited is ₹ 175.47 Cr and paid-up capital is ₹ 114.77 Cr.

  • Who are the current board members & directors of Intas Pharmaceuticals Limited?

    Currently 12 directors are associated with Intas Pharmaceuticals Limited.

    • Urmish Hasmukh Chudgar
    • Binish Hasmukh Chudgar
    • Hasmukh Chudgar
    • Sanjay Kukreja
    • Nimish Hasmukh Bhai Chudgar
    • Jayesh Shantilal Shah
    • Venkatesh Ratnasami
    • Archana Ravindrarai Dholakia
    • Jitesh Kishorekumar Gadhia
    • Rakesh Bamzai
    • Abhimanyu Ojha
    • Manoj Narayanan Nair

  • What is the registered address of Intas Pharmaceuticals Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Intas Pharmaceuticals Limited is Corporate House Near Sola Bridge S. G. Highway, Thaltej India, Ahmedabad, Gujarat, 380054.

  • What is the corporate identification number (CIN) and company number of Intas Pharmaceuticals Limited?

    The corporate identification number (CIN) of Intas Pharmaceuticals Limited is U24231GJ1985PLC007866 and the company number is 007866 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Intas Pharmaceuticals Limited?

    The Official website of Intas Pharmaceuticals Limited is https://www.intaspharma.com

  • What has been the recent revenue trend for Intas Pharmaceuticals Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Intas Pharmaceuticals Limited has fallen by -3.44%.

  • How many employees does Intas Pharmaceuticals Limited currently have?

    As Per 2023 financial reports, 19974 employees are currently employed by Intas Pharmaceuticals Limited.

  • What change has been observed in the net worth of Intas Pharmaceuticals Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Intas Pharmaceuticals Limited has experienced an upsurge of 13.06%.

  • What are the total open charges for Intas Pharmaceuticals Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Intas Pharmaceuticals Limited amount to ₹ 4.50 Cr.

  • When was the last Balance Sheet of Intas Pharmaceuticals Limited filed with the ROC?

    The most recent Balance Sheet for Intas Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development